Lava Therapeutics Nv Stock Performance
| LVTX Stock | USD 1.60 0.05 3.23% |
LAVA Therapeutics has a performance score of 2 on a scale of 0 to 100. The firm secures a Beta (Market Risk) of 1.74, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, LAVA Therapeutics will likely underperform. LAVA Therapeutics currently secures a risk of 4.05%. Please verify LAVA Therapeutics NV rate of daily change, and the relationship between the kurtosis and market facilitation index , to decide if LAVA Therapeutics NV will be following its current price movements.
Risk-Adjusted Performance
2 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in LAVA Therapeutics NV are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, LAVA Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024. ...more
1 | LAVA Therapeutics Short Interest Down 69.8 percent in September | 10/10/2024 |
| Begin Period Cash Flow | 100.3 M |
LAVA |
LAVA Therapeutics Relative Risk vs. Return Landscape
If you would invest 157.00 in LAVA Therapeutics NV on August 31, 2024 and sell it today you would earn a total of 3.00 from holding LAVA Therapeutics NV or generate 1.91% return on investment over 90 days. LAVA Therapeutics NV is currently generating 0.1091% in daily expected returns and assumes 4.0508% risk (volatility on return distribution) over the 90 days horizon. In different words, 36% of stocks are less volatile than LAVA, and 98% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
LAVA Therapeutics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for LAVA Therapeutics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as LAVA Therapeutics NV, and traders can use it to determine the average amount a LAVA Therapeutics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0269
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | LVTX | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.05 actual daily | 36 64% of assets are more volatile |
Expected Return
| 0.11 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average LAVA Therapeutics is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of LAVA Therapeutics by adding it to a well-diversified portfolio.
LAVA Therapeutics Fundamentals Growth
LAVA Stock prices reflect investors' perceptions of the future prospects and financial health of LAVA Therapeutics, and LAVA Therapeutics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on LAVA Stock performance.
| Return On Equity | -0.45 | ||||
| Return On Asset | -0.16 | ||||
| Operating Margin | (3.71) % | ||||
| Current Valuation | (38.56 M) | ||||
| Shares Outstanding | 26.3 M | ||||
| Price To Earning | 0.54 X | ||||
| Price To Book | 0.98 X | ||||
| Price To Sales | 5.69 X | ||||
| Revenue | 6.77 M | ||||
| Gross Profit | (20.71 M) | ||||
| EBITDA | (40.42 M) | ||||
| Net Income | (41.7 M) | ||||
| Cash And Equivalents | 110.71 M | ||||
| Cash Per Share | 4.29 X | ||||
| Total Debt | 6.31 M | ||||
| Debt To Equity | 0.05 % | ||||
| Current Ratio | 6.74 X | ||||
| Book Value Per Share | 1.63 X | ||||
| Cash Flow From Operations | (38.97 M) | ||||
| Earnings Per Share | (0.89) X | ||||
| Market Capitalization | 42.08 M | ||||
| Total Asset | 101.71 M | ||||
| Retained Earnings | (148.07 M) | ||||
| Working Capital | 83.96 M | ||||
About LAVA Therapeutics Performance
Evaluating LAVA Therapeutics' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if LAVA Therapeutics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if LAVA Therapeutics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 20.86 | 18.54 | |
| Return On Tangible Assets | (0.41) | (0.43) | |
| Return On Capital Employed | (0.50) | (0.52) | |
| Return On Assets | (0.41) | (0.43) | |
| Return On Equity | (0.82) | (0.86) |
Things to note about LAVA Therapeutics performance evaluation
Checking the ongoing alerts about LAVA Therapeutics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for LAVA Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| LAVA Therapeutics may become a speculative penny stock | |
| LAVA Therapeutics had very high historical volatility over the last 90 days | |
| LAVA Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 6.77 M. Net Loss for the year was (41.7 M) with loss before overhead, payroll, taxes, and interest of (20.71 M). | |
| LAVA Therapeutics NV currently holds about 110.71 M in cash with (38.97 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.29, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 29.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing LAVA Therapeutics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether LAVA Therapeutics' stock is overvalued or undervalued compared to its peers.
- Examining LAVA Therapeutics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating LAVA Therapeutics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of LAVA Therapeutics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of LAVA Therapeutics' stock. These opinions can provide insight into LAVA Therapeutics' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for LAVA Stock Analysis
When running LAVA Therapeutics' price analysis, check to measure LAVA Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LAVA Therapeutics is operating at the current time. Most of LAVA Therapeutics' value examination focuses on studying past and present price action to predict the probability of LAVA Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LAVA Therapeutics' price. Additionally, you may evaluate how the addition of LAVA Therapeutics to your portfolios can decrease your overall portfolio volatility.